New research involving Irish scientists could lead to effective new treatments for the most common type of arthritis within the next five years.
Scientists based at NUI Galway are part of an EU-funded project – ADIPOA – that is investigating how stem cells from adult fat tissue may be used to activate the regeneration of cartilage. This could lead to new treatments for the condition, osteoarthritis (OA).
OA usually develops gradually over several years, and affects a number of different joints. It is characterised by a degeneration of cartilage in these joints and can be very painful.
Around 400,000 people in Ireland and 70 million in the EU are affected by the condition
According to the scientists, the phase one clinical trial has just finished and early results have so far been positive. Based on these findings, a new and effective treatment for OA could become a reality within the next few years.
“Until now there were just two possible outcomes for suffers of this progressive and debilitating disease – joint replacement surgery, in the case of advanced disease or, life-long pain management. From the clinical trials conducted so far, we have seen the first signs of finding a cure for this truly incapacitating disease which affects so many,” commented Prof Frank Barry, scientific director of the Regenerative Medicine Institute (REMEDI) at NUI Galway and a partner in the ADIPOA project.
He pointed out that using the patient’s own stem cells, the scientists were able to ‘treat their diseased joints and relieve their suffering and burden of pain’.
“While we are still in the early stages of clinical trials, the results so far are extremely positive, such that the use of stem cell therapy for osteoarthritis could become a reality for patients within the next five years,” he insisted.
The Latest on: Arthritis
[google_news title=”” keyword=”Arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Arthritis
- Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Coston April 26, 2024 at 11:41 am
Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Evernorth is a subsidiary of The Cigna Group (NYSE:CI). Beginning in ...
- AbbVie’s Q1 earnings beat expectations as arthritis drug boosts growthon April 26, 2024 at 5:17 am
Pharmaceuticals company AbbVie reported its Q1 financial results for 2024 today. AbbVie’s earnings came in at $1.37B, or $0.77 per share.
- AbbVie’s first-quarter results top expectations as arthritis drugs fuel growthon April 26, 2024 at 4:37 am
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.
- Biogen's Tofidence Gets Positive CHMP Opinion For Rheumatoid Arthritis,Juvenile Arthritis & COVID-19on April 25, 2024 at 6:48 pm
Biogen Inc. (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA ...
- Sunset Zoo tiger receives groundbreaking new arthritis treatmenton April 25, 2024 at 1:49 pm
Beloved local tiger Hakim recently underwent groundbreaking arthritis treatment at Sunset Zoo. The 17-year-old tiger was treated at the Kansas State University College of Veterinary Medicine by Dr.
- John Ball Zoo’s lioness, 17, dies due to arthritis complicationson April 24, 2024 at 8:21 pm
GRAND RAPIDS, MI — John Ball Zoo’s lioness, Abena, has died due to complications with arthritis. Abena was a 17-year-old African lion, less than a month shy of turning 18. She came to John Ball Zoo ...
- Could low-dose naltrexone ease arthritis pain?on April 24, 2024 at 6:00 am
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found the active ingredient in Pepto Bismol turned their tongue black.
- Arthritis linked to blood cancer mutationson April 23, 2024 at 10:20 am
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
- Arthroscopic surgery for arthritis does not impact incidence of total knee arthroplasty, study findson April 23, 2024 at 10:09 am
The addition of arthroscopic surgery to nonoperative management of knee arthritis does not delay or hasten total knee arthroplasty (TKA) during 10 years of follow-up, according to a study published ...
- An arthritis drug helps old dogs, but some owners worry about side effectson April 20, 2024 at 5:33 am
Librela has been used for dog arthritis in Europe for three years. But in the United States, fears about a side effects have spread rapidly on social media.
via Bing News